Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Argus Health
Baxter
Cantor Fitzgerald
UBS
Farmers Insurance
Merck
McKinsey

Generated: February 19, 2019

DrugPatentWatch Database Preview

MEMBRANEBLUE Drug Profile

« Back to Dashboard

When do Membraneblue patents expire, and when can generic versions of Membraneblue launch?

Membraneblue is a drug marketed by Dorc and is included in one NDA. There are two patents protecting this drug.

This drug has forty-five patent family members in fourteen countries.

The generic ingredient in MEMBRANEBLUE is trypan blue. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trypan blue profile page.

Summary for MEMBRANEBLUE
International Patents:45
US Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
DailyMed Link:MEMBRANEBLUE at DailyMed
Drug patent expirations by year for MEMBRANEBLUE
Pharmacology for MEMBRANEBLUE
Drug ClassDiagnostic Dye
Mechanism of ActionDyes
Medical Subject Heading (MeSH) Categories for MEMBRANEBLUE

US Patents and Regulatory Information for MEMBRANEBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Merck
Harvard Business School
Cipla
Johnson and Johnson
Cantor Fitzgerald
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.